CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $153.23M, above the global median of $16.24M
- FinancialsAltman Z-Score 0.87: distress zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.84BCNY868.30M · vs all stocks (USD)
Revenue (TTM)
509.95MCNY75.84M · vs all stocks (USD)
Profit Margin
-2.76%Beta
0.2110xvs all stocks
52-Week Change
-55.03%vs all stocks
Market Capitalization
5.84BCNY868.30M · vs all stocks (USD)
Enterprise Value
8.63BCNY1.28B · vs all stocks (USD)
Forward P/E
5.26xPrice to Sales (TTM)
10.77xPrice to Book (MRQ)
0.9014xEnterprise to Revenue
16.91xEnterprise to EBITDA
-6.67xGross Margin
0.37%Profit Margin
-2.76%Operating Margin
-115.01%Return on Assets (TTM)
-7.84%Return on Equity (TTM)
-22.41%Revenue (TTM)
509.95MCNY75.84M · vs all stocks (USD)
Revenue per Share (TTM)
0.5430CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-61.30%Gross Profit (TTM)
-743.54MCNY-110.57M · vs all stocks (USD)
EBITDA (TTM)
-1.29BCNY-192.25M · vs all stocks (USD)
Net Income (TTM)
-1.62BCNY-241.17M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-73.17%Operating Cash Flow (TTM)
652.58MCNY97.05M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.03BCNY153.23M · vs all stocks (USD)
5-Year Average Dividend Yield
1.40%vs all stocks
Payout Ratio
85.51%Minority Interest (Equity)
-1.74MCNYFY2025 · Dec 31, 2025Revenue
798.06MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
820.12MCNYFY2025 · Dec 31, 2025Gross Profit
-22.06MCNYFY2025 · Dec 31, 2025Operating Income
-417.86MCNY-62.14M · vs all stocks (USD)
Pre-tax Income
-1.63BCNYFY2025 · Dec 31, 2025Income Tax Expense
-257.47MCNYFY2025 · Dec 31, 2025Net Income
-1.37BCNYFY2025 · Dec 31, 2025EBIT
-1.49BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-257.53MCNYFY2025 · Dec 31, 2025Research & Development
46.35MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
185.25MCNYFY2025 · Dec 31, 2025Other Operating Expenses
38.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
37.01MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
139.00MCNYFY2025 · Dec 31, 2025EPS (Basic)
-1.45CNYFY2025 · Dec 31, 2025EPS (Diluted)
-1.45CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
939.84MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
939.84MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-1.37BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.40MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-2.65BCNYFY2025 · Dec 31, 2025Free Cash Flow
-2.72BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
76.90MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-1.37BCNYFY2025 · Dec 31, 2025Other Non-cash Items
156.55MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-947.80MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-488.25MCNYFY2025 · Dec 31, 2025Capital Expenditures
-66.14MCNYFY2025 · Dec 31, 2025Purchase of Investments
-530.87MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-597.01MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.42BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.83BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-276.56MCNYFY2025 · Dec 31, 2025Other Financing Charges
-2.21MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-698.51MCNYFY2025 · Dec 31, 2025Shares Outstanding
941.00MSharesUpdated Aug 21, 2026Float Shares
389.60MSharesUpdated Aug 21, 2026% Held by Insiders
62.12%vs all stocks
% Held by Institutions
3.81%vs all stocks
Total Cash (MRQ)
59.00MCNY8.77M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.0630CNYUpdated Aug 21, 2026Total Debt (MRQ)
3.15BCNY468.08M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5128xCurrent Ratio (MRQ)
1.38xBook Value per Share (MRQ)
6.48CNYUpdated Aug 21, 2026Total Assets
10.63BCNY1.58B · vs all stocks (USD)
Total Current Assets
5.15BCNYFY2025 · Dec 31, 2025Total Liabilities
4.36BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.49BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
269.57MCNYFY2025 · Dec 31, 2025Total Current Liabilities
4.09BCNYFY2025 · Dec 31, 2025Cash
76.90MCNYFY2025 · Dec 31, 2025Cash Equivalents
2.02MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
78.91MCNYFY2025 · Dec 31, 2025Other Short-term Investments
438.51KCNYFY2025 · Dec 31, 2025Accounts Receivable
2.55BCNYFY2025 · Dec 31, 2025Inventory
1.32BCNYFY2025 · Dec 31, 2025Accounts Payable
341.10MCNYFY2025 · Dec 31, 2025Short-term Debt
3.07BCNYFY2025 · Dec 31, 2025Other Current Liabilities
30.27MCNYFY2025 · Dec 31, 2025Long-term Debt
53.20MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
58.11MCNYFY2025 · Dec 31, 2025Common Stock (Book)
941.00MCNYFY2025 · Dec 31, 2025Retained Earnings
2.55BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.28BCNY933.77M · vs all stocks (USD)
Treasury Stock
13.89MCNYFY2025 · Dec 31, 202552-Week Low
4.21CNYUpdated Aug 21, 202652-Week High
13.07CNYUpdated Aug 21, 202652-Week Change
-55.03%vs all stocks
Beta
0.2110xvs all stocks
50-Day MA
5.69CNYUpdated Aug 21, 2026200-Day MA
7.69CNYUpdated Aug 21, 2026Avg 10-Day Volume
87.76MSharesUpdated Aug 21, 2026Avg 30-Day Volume
82.89MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-1.73CNYUpdated Aug 21, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Sharp Decline With Volume And Volatility Expansion
A steep fall on heavy volume, leaving the price far below its peak.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.87: distress zoneCritical
Altman Z-Score: 0.87
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $153.23M, above the global median of $16.24MNotable
Levered free cash flow (USD): 153,228,604.506Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Hunan Warrants Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Oxford Biomedica plc
Tier 1ProductionApproval-Gated PipelineFlowRule
Amphastar Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Phathom Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jinghua Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Kaibao Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sana Biotechnology, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Theravance Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Replimune Group Inc.
Tier 1ProductionApproval-Gated PipelineRule
Solid Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Wintao Communications Co.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSharp Decline With Volume And Volatility Expansion
Hyundai Department Store Co., Ltd.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSharp Decline With Volume And Volatility Expansion
Doximity Inc.
2 interpretationsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSharp Decline With Volume And Volatility Expansion